机译:特拉内洛替纳米适用于中度至重度的特征性皮炎:结果来自两个52周,随机,双盲,多期,安慰剂控制的第三阶段试验(Ecztra 1和Ecztra 2)
Ludwig Maximilian Univ Munich Dept Dermatol &
Allergy Munich Germany;
Oregon Med Res Ctr Portland OR USA;
Icahn Sch Med Mt Sinai Dept Dermatol New York NY 10029 USA;
Charit Univ Med Berlin Div Allergy &
Immunol Dept Dermatol Venereol &
Allergy Berlin Germany;
Prob Med Res Lynde Dermatol Markham ON Canada;
Univ Hosp Nice Dept Dermatol Nice France;
Verac Clin Res Brisbane Qld Australia;
Kyoto Prefectural Univ Med Grad Sch Med Sci Dept Dermatol Kyoto Japan;
Nippon Med Sch Dept Dermatol Tokyo Japan;
Laval Univ Quebec City PQ Canada;
Med Univ Lodz Dept Dermatol &
Pediat &
Oncol Dermatol Lodz Poland;
Icahn Sch Med Mt Sinai New York NY 10029 USA;
Catholic Univ Korea Dept Dermatol Seoul South Korea;
Hosp Univ La Paz Dept Dermatol Madrid Spain;
Univ Sheffield Sheffield Dermatol Res Dept Infect Immun &
Cardiovasc Dis Sheffield S Yorkshire;
Catholic Univ Dermatol Rome Italy;
LEO Pharma AS Ballerup Denmark;
LEO Pharma AS Ballerup Denmark;
LEO Pharma AS Ballerup Denmark;
LEO Pharma AS Ballerup Denmark;
LEO Pharma AS Ballerup Denmark;
Oregon Hlth &
Sci Univ Dept Dermatol Portland OR 97201 USA;
机译:Tralokinumab加上局部皮质类固醇治疗中度至严重的特征性皮炎:由双盲,随机,多期,安慰剂对照期III eCZTRA 3试验的结果
机译:97分三丙氨酸与局部皮质类固醇(TCS)提高了具有中度至严重的特征性皮炎(广告)的成人身份健康相关的生活质量(HRQOL):2B期,随机,双盲,安慰剂对照研究
机译:96 ralokinumab在成年患者中显着减少了成年患者的金黄色葡萄球菌殖民症(AD):2B相,随机,双盲,安慰剂对照研究的结果(NCT02347176)
机译:靶向脉冲电磁场治疗对犬术后血栓切除术的影响:双盲,随机,安慰剂对照临床试验
机译:鱼油(二十碳五烯酸和二十二碳六烯酸)对急性肺损伤患者的肺和全身炎症的II期,随机,双盲,安慰剂对照试验。
机译:系统性红斑狼疮(BEAT狼疮)患者进行B细胞耗竭治疗后的Belimumab方案:一项前瞻性多中心双盲随机安慰剂对照52周的II期临床试验
机译:特拉内洛替尼布单药治疗成人患者中度至重度的特征性皮炎的疗效和安全性:结果来自2阶段3阶段试验(eCZTRA 1和ECZTRA 2)
机译:秘鲁健康婴儿和儿童两种黄热病17D疫苗(aRILVaX(商标)和YF-VaX(商标))的比较免疫原性安全性和耐受性的随机双盲III期关键现场试验